Related Articles
Clinical efficacy of CyberKnife combined with chemotherapy and hyperthermia for advanced non‑small cell lung cancer
Early efficacy of stereotactic body radiation therapy combined with adoptive immunotherapy for advanced malignancies
Optimized treatment with RF thermotherapy and immunotherapy combined with CyberKnife for advanced high‑risk tumors: A clinical trial report
CyberKnife therapy of 24 multiple brain metastases from lung cancer: A case report
Dendritic cell-activated cytokine-induced killer cell-mediated immunotherapy is safe and effective for cancer patients >65 years old